Novavax Says Well-Prepared With A Solid EUA Application For Covid-19 Vaccine, Expect FDA Response In February- JPM Conf

Jan 10 (Reuters) - Novavax Inc:

* NOVAVAX EXEC SAYS INITIAL 27 MILLION DOSE ORDER FOR COVID-19 VACCINE FROM EU TO BE SHIPPED IN Q1 WAS EXPANDED TO INCLUDE 42 MILLION MORE DOSES TO BE DELIVERED IN Q2- JPM CONF

* NOVAVAX EXEC SAYS DELIVERED 10 MILLION DOSES TO INDONESIA AND WILL DELIVER ANOTHER 40 MILLION DOSES OVER THE COMING QUARTERS- JPM CONF

* NOVAVAX EXEC SAYS BEGAN SHIPPING DOSES INTO OUR EUROPEAN DISTRIBUTION HUB- JPM CONF

* NOVAVAX EXEC SAYS TOO EARLY TO SAY IF OMICRON-SPEFCIFIC VACCINE IS THE RIGHT APPROACH OR IF ORIGINAL COVID-19 VACCINE GENERATES A SUFFICIENTLY BROAD PROTECTIVE RESPONSE TO USE AS A BOOST- JPM CONF

* NOVAVAX EXEC SAYS COMPANY IS WELL-PREPARED WITH A SOLID EUA APPLICATION FOR COVID-19 VACCINE, EXPECT A RESPONSE FROM U.S. FDA IN FEBRUARY- JPM CONF Source text for Eikon: Further company coverage: